HOLX vs. PHG, QGEN, CUTR, BDX, IDXX, EW, RMD, DXCM, STE, and BAX
Should you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Koninklijke Philips (PHG), Qiagen (QGEN), Cutera (CUTR), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), STERIS (STE), and Baxter International (BAX).
Koninklijke Philips (NYSE:PHG) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.
Koninklijke Philips has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
Hologic has a net margin of 11.78% compared to Hologic's net margin of -4.41%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.
Hologic received 482 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.73% of users gave Hologic an outperform vote while only 56.73% of users gave Koninklijke Philips an outperform vote.
Hologic has a consensus target price of $85.55, indicating a potential upside of 8.79%. Given Koninklijke Philips' stronger consensus rating and higher probable upside, analysts clearly believe Hologic is more favorable than Koninklijke Philips.
In the previous week, Hologic had 9 more articles in the media than Koninklijke Philips. MarketBeat recorded 14 mentions for Hologic and 5 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.72 beat Hologic's score of 0.44 indicating that Hologic is being referred to more favorably in the news media.
Hologic has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.8% of Hologic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Hologic beats Koninklijke Philips on 17 of the 18 factors compared between the two stocks.
Get Hologic News Delivered to You Automatically
Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
Free HOLX Stock Alerts